BHARAT BIOTECH
COVID-19 Vaccine Update: Air Cargo Operators, Airports Planning Steps to Ensure Smooth Transport of Coronavirus Vaccines
Covaxin Volunteer Showed Adverse Effect During Phase 1 Trials, Says Report; Bharat Biotech Claims Illness 'Unrelated' to Vaccine
Haryana Health Minister Anil Vij Volunteers for Covaxin Phase 3 Trials; Bharat Biotech's COVID-19 Vaccine To Begin Trials in State from November 20
COVID-19 Vaccine in India Update: Vaccinating 130 Crore People With Injectable Covaxin a Challenge, Says Bharat Biotech
COVID-19 Vaccine Update: Bharat Biotech's COVAXIN Vaccine Could be Launched as Early as February 2021, Says ICMR Senior Scientist
Coronavirus Vaccine Covaxin, Developed by Bharat Biotech, Likely to be Launched in Second Quarter of Year 2021
COVID-19 Vaccine: Bharat Biotech to Conduct Phase-3 Trials of Covaxin in 26,000 Volunteers
COVID-19 Vaccine Update: Covaxin By Bharat Biotech Cleared For Phase 3 Trials By The Drugs Controller General Of India (DCGI)
COVID-19 Vaccine Update: Sputnik V To Undergo Trial In India, Dr Reddy’s Gets DCGI Approval, Serum Institute, Bharat Biotech To Start Intranasal Vaccine Trials
Bharat Biotech, Serum Institute of India Developing Intranasal Vaccines for COVID-19; What Is an Intranasal Vaccine? Updates on Anti-Coronavirus Intranasal Vaccines’ Development
COVID-19 Vaccine Update: Bharat Biotech & Washington University Developing Nasal Vaccine for Coronavirus, Says Harsh Vardhan
COVID-19 Vaccine Development: Major Updates on Oxford-AstraZeneca, Johnson & Johnson, Sputnik V, Bharat Biotech & Sinopharm Candidates
COVID-19 Vaccine: Bharat Biotech Asked to Submit Complete Phase 2 Data of Its Vaccine Before Phase 3 Clinical Trial
COVID-19 Vaccine Update: Phase-3 Trial of COVAXIN to Begin in UP's Lucknow, Gorakhpur from October
COVID-19 Vaccine: Bharat Biotech Inks Pact with Washington University School of Medicine for Coronavirus Intranasal Vaccine
Google Trends